Created at 12:01 a.m. May, 27, 2025
Author:
joshuamb
Type of change:
Content error
Rationale for change
check AMBOSS here: https://next.amboss.com/us/article/kT0mI2?utm_source=anki&utm_medium=anki&utm_campaign=anki&utm_term=polycythemia%2Bvera&guid=xpfS%2540tKV%252BZ&aid=ed8a98c7-bb92-4fbe-87d0-0bcce94ba0ed&uid=-OiSDE7za#Z86941b92e2c44caf6d6becf9171d08b2
Hydroxyurea is an adjunct to be started on high risk patients or low-risk patients with persistent symptoms. For ALL patients you should be doing phlebotomy + aspirin. Therefore the word 'alternative' in this prompt is misleading and should be changed to additional or even "second line".
Current
Suggested
Text
Text
Text
Text
Extra
* first-line treatment for polycythemia vera is repeated phlebotomy
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy




Watch Polycythemia



Watch Myeloproliferative Neoplasms & Myelodysplastic Syndromes



Watch Methotrexate, Leucovorin, 5-fluorouracil, Hydroxyurea




Watch Polycythemia



Watch Myeloproliferative Neoplasms & Myelodysplastic Syndromes



Watch Methotrexate, Leucovorin, 5-fluorouracil, Hydroxyurea
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Principles of Oncology and Therapeutics: Cell Cycle Dependent Drug Targets
Watch associated Bootcamp video - Plasma Cell Dyscrasias and Myeloproliferative Disease: Polycythemia Vera and Essential Thrombocythemia
Watch associated Bootcamp video - Cellular Injury and Neoplasia: Cell Cycle Dependent Drug Targets
Watch associated Bootcamp video - DNA Structure : Clinical Applications of the Pyrimidine Pathway
Watch associated Bootcamp video - Plasma Cell Dyscrasias and Myeloproliferative Disease: Polycythemia Vera and Essential Thrombocythemia
Watch associated Bootcamp video - Cellular Injury and Neoplasia: Cell Cycle Dependent Drug Targets
Watch associated Bootcamp video - DNA Structure : Clinical Applications of the Pyrimidine Pathway
OME
Additional Resources
Empty field
One by one
Empty field
